Mark Auerbach
Director at Pardes Biosciences, Inc. (PRDS)
Mark Auerbach has filed 5 insider reports with the SEC since December 2021, as director at Pardes Biosciences, Inc. (PRDS) and director at Pardes Biosciences, Inc. (FSII). The latest filing, on August 31, 2023, reports sale back to the company and tender of shares in a change of control at Pardes Biosciences, Inc. (PRDS).
- Filings
- 5
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Mark Auerbach is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 0 | Aug 31, 2023 | |||||
| Directorsince December 2021 | 70,390 | Dec 28, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 31, 2023PRDSSEC Form 4: Auerbach Mark closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Jun 1, 2023PRDSSEC Form 4 filed by Auerbach MarkForm 4Grant or award
- Jun 8, 2022PRDSSEC Form 4 filed by Auerbach MarkForm 4Grant or award
- Dec 23, 2021FSIISEC Form 4 filed by Auerbach MarkForm 4Grant or award
- Dec 23, 2021FSIISEC Form 3: New insider Auerbach Mark claimed ownership of 70,390 sharesForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Mark Auerbach.
- James B. Tananbaum2 shared: PRDS, FSII
- Michael David Varney2 shared: PRDS, FSII
- Uri A Lopatin2 shared: PRDS, FSII
- J Jay Lobell2 shared: PRDS, FSII
- Elizabeth H. Lacy2 shared: PRDS, FSII
- Heidi Henson2 shared: PRDS, FSII
- Laura Hamill2 shared: PRDS, FSII
- Deborah M. Autor2 shared: PRDS, FSII
- Sean P. Brusky2 shared: PRDS, FSII
- Brian Kearney2 shared: PRDS, FSII
- Brian Philippe Tinmouth2 shared: PRDS, FSII
- Lee D Arnold2 shared: PRDS, FSII
Compare Mark Auerbach with
- Mark Auerbach vs James B. Tananbaum2 shared
- Mark Auerbach vs Michael David Varney2 shared
- Mark Auerbach vs Uri A Lopatin2 shared
- Mark Auerbach vs J Jay Lobell2 shared
- Mark Auerbach vs Elizabeth H. Lacy2 shared
- Mark Auerbach vs Heidi Henson2 shared
Questions about Mark Auerbach
- What is Mark Auerbach's role at Pardes Biosciences, Inc.?
- Mark Auerbach reports to the SEC as director at Pardes Biosciences, Inc. (PRDS), according to the latest filing on August 31, 2023. Mark Auerbach has also filed as director at Pardes Biosciences, Inc. (FSII).
- How many shares does Mark Auerbach own?
- After the latest filing that states it, Mark Auerbach directly owned 70,390 shares of Pardes Biosciences, Inc. (FSII). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Auerbach bought or sold stock recently?
- No open-market purchases or sales by Mark Auerbach are on file. The filings report sale back to the company, tender of shares in a change of control and grant or award.
- How do I get alerts when Mark Auerbach files?
- Follow Mark Auerbach on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mark Auerbach (SEC CIK 0001018007). Totals count each trade once, skipping amendments whose original is on file, from Dec 27, 2021 on. View on SEC EDGAR